31/12/2025
10:52 AM
|
|
Application for quotation of securities - NUZ
5
pages
17.0KB
|
23/12/2025
12:58 PM
|
|
Section 708A Cleansing Statement
2
pages
241.6KB
|
23/12/2025
11:51 AM
|
|
Application for quotation of securities - NUZ
6
pages
18.5KB
|
23/12/2025
9:51 AM
|
|
Notice under s708AA(2)(f)
2
pages
250.1KB
|
23/12/2025
9:51 AM
|
|
Proposed issue of securities - NUZ
6
pages
22.4KB
|
23/12/2025
9:50 AM
|
|
Proposed issue of securities - NUZ
9
pages
30.8KB
|
23/12/2025
9:50 AM
|
|
Equity Raising Presentation
53
pages
3.5MB
|
23/12/2025
9:49 AM
|
|
New Funding Secured for HEALEY ALS Platform Trial
11
pages
457.9KB
|
19/12/2025
9:13 AM
|
|
Trading Halt
2
pages
373.0KB
|
11/12/2025
8:27 AM
|
|
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
2
pages
252.9KB
|
04/12/2025
8:54 AM
|
|
Neurizon Completes GMP Tablet Registration Batches
2
pages
246.6KB
|
03/12/2025
2:35 PM
|
|
Amended Constitution
63
pages
914.4KB
|
26/11/2025
7:05 PM
|
|
Results of Annual General Meeting
4
pages
439.4KB
|
26/11/2025
2:51 PM
|
|
AGM Presentation
24
pages
2.7MB
|
26/11/2025
2:49 PM
|
|
Chairman's AGM Address
3
pages
263.3KB
|
26/11/2025
9:16 AM
|
|
Elanco executive appointed as Board Observer
2
pages
188.8KB
|
31/10/2025
3:27 PM
|
|
Section 708A Cleansing Statement
2
pages
343.1KB
|
31/10/2025
3:17 PM
|
|
Application for quotation of securities - NUZ
6
pages
18.3KB
|
31/10/2025
9:35 AM
|
|
Neurizon to present Q1 FY2026 Results
24
pages
2.7MB
|
29/10/2025
9:42 AM
|
|
Appendix 4C & Quarterly Update
12
pages
729.3KB
|
23/10/2025
9:15 AM
|
|
Notice of Annual General Meeting/Proxy Form
26
pages
719.2KB
|
21/10/2025
9:09 AM
|
|
Australian Patent Granted for NUZ-001
2
pages
395.6KB
|
20/10/2025
4:17 PM
|
|
Quarterly Shareholder Update Webinar - Q1 FY2026
1
page
344.1KB
|
10/10/2025
8:41 AM
|
|
Neurizon to Present Poster Data at 2025 NEALS Annual Meeting
7
pages
3.5MB
|
08/10/2025
9:35 AM
|
|
Proposed issue of securities - NUZ
5
pages
17.4KB
|
08/10/2025
9:30 AM
|
|
Neurizon Commences Trading on OTCQB Venture Market
3
pages
407.1KB
|
06/10/2025
8:55 AM
|
|
FDA Lifts Clinical Hold on NUZ-001
2
pages
448.4KB
|
01/10/2025
5:44 PM
|
|
Notification regarding unquoted securities - NUZ
7
pages
22.2KB
|
24/09/2025
9:32 AM
|
|
Section 708A Cleansing Statement
2
pages
341.6KB
|
23/09/2025
11:24 AM
|
|
Application for quotation of securities - NUZ
5
pages
16.9KB
|
18/09/2025
9:25 AM
|
|
R&D Tax Incentive Advance & Overseas Finding Approval
2
pages
325.8KB
|
18/09/2025
9:25 AM
|
|
Proposed issue of securities - NUZ
5
pages
19.0KB
|
18/09/2025
9:25 AM
|
|
Neurizon Raises $5m via Institutional Placement
2
pages
419.2KB
|
16/09/2025
9:29 AM
|
|
Trading Halt
2
pages
285.6KB
|
01/09/2025
6:32 PM
|
|
Change of AGM Date
1
page
263.4KB
|
26/08/2025
10:47 AM
|
|
Neurizon to present Q4 updates to Shareholders
32
pages
2.6MB
|
26/08/2025
9:41 AM
|
|
Appendix 4G and Corporate Governance Statement
25
pages
833.8KB
|
26/08/2025
9:34 AM
|
|
Appendix 4E and 2025 Annual Report
76
pages
3.7MB
|
20/08/2025
4:14 PM
|
|
Notice of Shareholder Update Webinar
2
pages
349.3KB
|
20/08/2025
9:32 AM
|
|
NUZ-001 Shows Long-Term Safety and Efficacy Signals in OLE
24
pages
3.8MB
|
15/08/2025
9:54 AM
|
|
FDA Review Timeline Extended for NUZ-001 IND Clinical Hold
2
pages
310.0KB
|
12/08/2025
9:30 AM
|
|
Neurizon Commences Manufacture of First Registration Batch
2
pages
417.5KB
|
05/08/2025
9:03 AM
|
|
AGM Date & Director Nominations Closing Date for AGM
1
page
280.2KB
|
30/07/2025
9:14 AM
|
|
Appendix 4C & Quarterly Update
13
pages
1.0MB
|
30/07/2025
9:10 AM
|
|
Neurizon Secures Loan Against 2025 R&D Tax Rebate
2
pages
377.9KB
|
25/07/2025
9:22 AM
|
|
Neurizon Submits Clinical Hold Complete Response to FDA
2
pages
439.7KB
|
10/07/2025
9:15 AM
|
|
Positive feedback from FDA on strategy to lift clinical hold
2
pages
354.5KB
|
02/07/2025
12:20 PM
|
|
Presentation Materials - Licensing Agreement Webinar
12
pages
1.4MB
|
02/07/2025
8:58 AM
|
|
Invitation to Shareholder Webinar
2
pages
307.7KB
|
02/07/2025
8:49 AM
|
|
Neurizon Enters Global Licensing Agreement with Elanco
2
pages
389.2KB
|
26/06/2025
5:57 PM
|
|
Notification regarding unquoted securities - NUZ
7
pages
23.1KB
|
26/06/2025
9:24 AM
|
|
Neurizon develops liquid formulation of NUZ-001
2
pages
401.4KB
|
20/06/2025
9:32 AM
|
|
NUZ-001 Shows Significant Blood-Brain Barrier Penetration
3
pages
521.0KB
|
16/06/2025
7:12 PM
|
|
Release of Securities from Escrow
1
page
280.4KB
|
16/06/2025
9:32 AM
|
|
NUZ-001 Shows Promise in a Model of Huntington's Disease
4
pages
1.6MB
|
02/06/2025
9:45 AM
|
|
Change of Registered Office and Principal Place of Business
1
page
165.0KB
|
14/05/2025
4:54 PM
|
|
Neurizon to present at Annual ALS Drug Development Summit
27
pages
5.8MB
|
06/05/2025
12:48 PM
|
|
Neurizon to present Q3 FY2025 Results
22
pages
1.7MB
|
05/05/2025
9:23 AM
|
|
Last Patient Successfully Completes Treatment in OLE Study
3
pages
714.5KB
|
28/04/2025
9:11 AM
|
|
Appendix 4C & Quarterly Update
14
pages
997.3KB
|
24/04/2025
9:28 AM
|
|
Notice of Quarterly Shareholder Update Webinar
2
pages
183.8KB
|
22/04/2025
9:28 AM
|
|
Appointment of Chief Financial Officer
2
pages
375.4KB
|
17/04/2025
9:22 AM
|
|
Leadership team strengthened with strategic appointments
3
pages
208.5KB
|
04/04/2025
12:07 PM
|
|
NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
4
pages
7.2MB
|
01/04/2025
9:03 AM
|
|
NUZ-001 Shows Positive Results in Human 3D Brain Model
4
pages
1.7MB
|
24/03/2025
9:47 AM
|
|
NUZ-001 shows promising respiratory outcome
4
pages
759.0KB
|
17/03/2025
9:22 AM
|
|
Neurizon Commences Initiatives to Lift Clinical Hold
2
pages
358.8KB
|
17/02/2025
2:28 PM
|
|
Appendix 4D - Half-year Financial Report - 31 December 2024
25
pages
1.3MB
|
17/02/2025
9:27 AM
|
|
Neurizon to Present Latest Results and Key Updates
23
pages
7.1MB
|
17/02/2025
9:14 AM
|
|
FDA Guidance on NUZ-001 IND Application
2
pages
353.2KB
|
11/02/2025
2:29 PM
|
|
Notice of Company Update Webinar
2
pages
345.4KB
|
07/02/2025
9:58 AM
|
|
Change of Director's Interest Notices x3
9
pages
748.1KB
|
05/02/2025
9:18 AM
|
|
US Patent granted for NUZ-001
2
pages
387.5KB
|
31/01/2025
4:46 PM
|
|
Notification regarding unquoted securities - NUZ
7
pages
21.9KB
|
29/01/2025
9:14 AM
|
|
Appendix 4C & Quarterly Update
10
pages
863.0KB
|
17/01/2025
9:59 AM
|
|
Neurizon updates on NUZ-001 IND Application
2
pages
308.7KB
|
16/01/2025
8:19 AM
|
|
Change of Share Registry
2
pages
329.0KB
|